Animal Models of Neurological Disorders: Where Are We Now? (3rd Edition)
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: 31 July 2025 | Viewed by 813
Special Issue Editor
Interests: brain development and regeneration; development of dopamine and GABA neurons; control of gene expression; transgenic models; evolution of developmental mechanisms; zebrafish models of disease including Parkinson's disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Animal models are powerful tools for investigating the key principles and underlying mechanisms of diseases and disorders. The use of animal models has allowed us to conduct various types of experiments and interrogate the mechanisms underlying diseases and disorders in manners that are unfeasible and unthinkable to apply to human patients. The usefulness of any animal model depends on various parameters such as predictive validity, symptoms, similarity to human conditions, and tractability. To date, various mammalian and non-mammalian animal models of neurological disorders have been established and characterized. They reflect the genetics, behavioral, and/or electrophysiological phenotypes of human patients.
There are various neurological disorders but, in this Issue, we are mainly focusing on five prominent disorders: Parkinson’s disease, Alzheimer’s disease, epilepsy, Huntington’s disease, and schizophrenia. This Special Issue will provide experimental evidence, updated views, and new treatment strategies regarding these disorders. Critical discussions on the advantages and limitations of animal models used to mirror these neurological disorders are also welcome. This Special Issue will cover original articles and reviews on every aspect of mammalian and non-mammalian animal models of Parkinson’s disease, Alzheimer’s disease, epilepsy, Huntington’s disease, and schizophrenia. This may include (but is not limited to) genetic, pharmacological, chemogenetic (such as DREADDs), and optogenetic models of neurological disorders. In this Issue, we also encourage authors to submit work on rare neurological and developmental disorders which affect the brain, spinal cord, or peripheral nerves.
Moreover, we encourage submissions on novel tools and methods related to animal models of the abovementioned neurological disorders as well. Tools and methods will only be considered if they are novel, well documented, discussed, and have the potential to be useful to the scientific world.
Prof. Dr. Marc Ekker
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- animal model of neurological disorders
- Parkinson’s disease
- Alzheimer’s disease
- epilepsy
- seizures
- Huntington’s disease
- schizophrenia
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
